Suchergebnisse - "Cai, Shangli"

PubPharm (109)

1

Prospective observational study on biomarkers of response in pancreatic ductal adenocarcinoma

enthalten in: Nature medicine | 2024

von Jiang, L. | Qin, J. | Dai, Y. | +42

2

A 15-Inflammation-Related Gene Signature Predicts the Prognosis of Patients With Pancreatic Ductal Adenocarcinoma

enthalten in: Cancer investigation | 2024

von Sun, X. | Song, H. | Sun, X. | +10

3

The prognostic significance and clinical relevance of stem cell characteristic in bladder cancer

enthalten in: Heliyon | 2024

von Chen, X. | Yin, Y. | He, Y. | +11

4

MAEL in human cancers and implications in prognostication and predicting benefit from immunotherapy over VEGFR/mTOR inhibitors in clear cell renal cell carcinoma : a bioinformatic analysis

enthalten in: Aging | 2024

von Tao, J. | Cui, J. | Xu, Y. | +10

5

Notch activation defines immune-suppressive subsets of ccRCCs with unfavorable benefits from immunotherapy over VEGFR/mTOR inhibitors

enthalten in: iScience | 2024

von Han, S. | Xu, Y. | Chen, D. | +9

6

T proliferating cells derived autophagy signature associated with prognosis and immunotherapy resistance in a pan-cancer analysis

enthalten in: iScience | 2024

von Fan, Z. | Liu, Y. | Li, C. | +11

7

Tumor-immune microenvironment and NRF2 associate with clinical efficacy of PD-1 blockade combined with chemotherapy in lung squamous cell carcinoma

enthalten in: Cell reports. Medicine | 2023

von Duan, J. | Zhang, Y. | Chen, R. | +19

8

IMPACT : A web server for exploring immunotherapeutic predictive and cancer prognostic biomarkers

enthalten in: Clinical and translational medicine | 2023

von Liu, Y. | Zhang, Y. | Xie, W. | +16

9

Complement and coagulation cascades pathway-related signature as a predictor of immunotherapy in metastatic urothelial cancer

enthalten in: Aging | 2023

von Gong, Z. | He, Y. | Mi, X. | +10

10

BAP1-related signature predicts benefits from immunotherapy over VEGFR/mTOR inhibitors in ccRCC : a retrospective analysis of JAVELIN Renal 101 and checkmate-009/010/025 trials

enthalten in: Cancer immunology, immunotherapy : CII | 2023

von Liu, K. | Huang, Y. | Xu, Y. | +4

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[11]